![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Evans Marc
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.66, Iss.15, 2006-01, pp. : 2002-2004
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Henness Sheridan Keam Susan J.
Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
By He Yan-Ling
Clinical Pharmacokinetics, Vol. 51, Iss. 3, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs & Therapy Perspectives, Vol. 23, Iss. 3, 2007-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vildagliptin: First report of acute pancreatitis: case report
Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vildagliptin validates its value in T2DM
Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. :